Clinical Trial

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To investigate progression-free survival (PFS) in patients with metastatic colorectal cancer treated with chemotherapy FOLFIRI monotherapy or chemotherapy FOLFIRI combined with Metformin
Trial Details
NCT Number NCT06826092
Lead Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions Progression-Free Survival
Enrollment 110 participants
Start Date 2022-10-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-13